G Marie Darrow, PA
Surgical · Danbury, CTNPI 1437190618
Payments from drug & device makers
What this record shows
Smith+Nephew accounts for 64.6% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $1,571 and has fallen 73.6% since, to $415 in 2025. Among surgical clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 30 payments — averaging $92.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$2K
- Stryker$216
- Davol Inc.$214
- Bioventus LLC$177
- Ferring Pharmaceuticals Inc.$138
- Heron Therapeutics, Inc.$125
- plus $114 from 4 others
What the payments were for
- Travel & lodging$1,32448%
- Food & beverage$1,45952%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 10 | $1,798 |
| Stryker | 2 | $216 |
| Davol Inc. | 2 | $214 |
| Bioventus LLC | 4 | $177 |
| Ferring Pharmaceuticals Inc. | 7 | $138 |
| Heron Therapeutics, Inc. | 1 | $125 |
| Saluda Medical Americas, Inc. | 1 | $34 |
| Vertex | 1 | $34 |
| Amgen | 1 | $25 |
| GSK | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- POLARSTEM$1,089
- Anthology$778
- OR3O Dual Mobility$778
- Tandem$778
- RI.HIP NAVIGATION$778
- R3$311
- POLAR3$311
- ARISTA AH FLEXITIP$180
- MAKO$157
- Zynrelef$125
- XCELL$115
How this compares
$2,783 in reported general payments places this provider in the 90th percentile of 568 surgical providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 69 | $1,510 |
| Methocarbamol | 67 | $562 |
| Meloxicam | 91 | $286 |
| Oxycodone Hcl | 55 | $271 |
| Pantoprazole Sodium | 41 | $157 |
| Mupirocin | 19 | $155 |
| Cefadroxil | 21 | $137 |
| Methylprednisolone | 24 | $122 |
| Tizanidine Hcl | 26 | $101 |
| Tramadol Hcl | 36 | $84 |
| Hydromorphone Hcl | 11 | $52 |
Paid to pharmacies, not to this prescriber.
Other surgical in Danbury
- Kristin AponteDanbury$6K
- Samuel SilvaDanbury$3K
- Erin Myers AlbaridiNorwalk$70K
- Christopher MascioStamford$44K
- Scott CallahanMonroe$31K
- Monika Hoang-SkawinskaMiddletown$17K
- Danielle MundayNorwalk$13K
- Megan StrongBridgeport$11K
- Ryan ArtigliereNew Haven$10K
- Arya BiswasNorwich$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.